Shift Bioscience vs Life Biosciences

UK biotech using AI and aging clocks to discover single-gene factors that safely rejuvenate cells, led by its SB000 target.

Develops partial epigenetic reprogramming medicines using OSK transcription factors to restore aged cells toward a younger state.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →